Legal Representation
Attorney
Danielle Rivera
USPTO Deadlines
Next Deadline
73 days remaining
NOA E-Mailed - SOU Required
Due Date
March 30, 2026
Extension Available
Until September 30, 2026
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 30, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 22, 2025 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED | Loading... |
| Sep 21, 2025 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Sep 20, 2025 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED | Loading... |
| Sep 18, 2025 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Aug 21, 2025 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| Aug 11, 2025 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Aug 4, 2025 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Mar 13, 2025 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Feb 11, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 11, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 5, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 16, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 15, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 15, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 15, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 19, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 19, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 19, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 18, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 29, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 2, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers, all of the foregoing excluding topical pharmaceutical preparations and pharmaceutical preparations for the prevention and treatment of ophthalmic diseases or disorders
Class 010
Medical apparatus for introducing pharmaceutical preparations into the human body; implantable medical device for introducing
pharmaceutical preparations into the human body, all of the foregoing excluding medical apparatus and medical devices for use in
the ophthalmic field
Classification
International Classes
005
010